4.5 Article

Phenoxy- and Phenylamino-Heterocyclic Quinones: Synthesis and Preliminary Anti-Pancreatic Cancer Activity

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Chemistry, Multidisciplinary

Pseudo Natural Products-Chemical Evolution of Natural Product Structure

George Karageorgis et al.

Summary: PNPs are compounds formed by combining NP fragments in unique ways, inheriting important biological characteristics of NPs while exhibiting unprecedented bioactivity. The importance of design principles, synthesis, and biological research on PNP scaffolds is emphasized. PNPs are considered as a human-driven branch of the evolution of natural product structure.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Biochemistry & Molecular Biology

New benzimidazolequinones as trypanosomicidal agents

Claudia Lopez-Lira et al.

Summary: The design and synthesis of new 2-phenyl(pyridinyl)benzimidazolequinones and their 5-phenoxy derivatives demonstrate potent anti-Trypanosoma cruzi activity. Compound 11a shows significantly higher activity compared to nifurtimox. Molecular docking studies suggest that these compounds could have a multitarget profile.

BIOORGANIC CHEMISTRY (2021)

Review Oncology

Future directions in drug development in pancreatic cancer

Aurelien Lambert et al.

Summary: Pancreatic cancer treatment remains a major challenge with minimal groundbreaking changes in the past 30 years, highlighting the urgent need for new treatment options and pathways for improvement, such as encapsulated agents, new generation targeted therapies, and treatments directed against the tumor microenvironment.

SEMINARS IN ONCOLOGY (2021)

Review Oncology

Treatment landscape of metastatic pancreatic cancer

Sara De Dosso et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a poor prognosis. Early diagnosis is challenging due to lack of symptoms, and treatment options include FOLFIRINOX and gemcitabine plus nab-paclitaxel depending on patient characteristics. The lack of molecular and genetic biomarkers hinders optimal patient stratification and treatment decisions, highlighting the need for further research on predictive and prognostic biomarkers and novel treatment strategies to improve outcomes for metastatic pancreatic cancer patients.

CANCER TREATMENT REVIEWS (2021)

Article Multidisciplinary Sciences

Natural product fragment combination to performance-diverse pseudo-natural products

Michael Grigalunas et al.

Summary: Natural product structure and fragment-based compound development inspire the design of pseudo-natural products through combinations of fragments to create chemically and biologically diverse compound classes. A library of 244 pseudo-natural products was synthesized and evaluated in cell painting essays, revealing the phenotypic role of individual fragments in determining bioactivity.

NATURE COMMUNICATIONS (2021)

Review Cell Biology

The biological underpinnings of therapeutic resistance in pancreatic cancer

Gregory L. Beatty et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related mortality in the United States, with a low survival rate of 10% over 5 years. The disease demonstrates remarkable adaptability and resistance to therapeutic intervention, contributing to its poor prognosis. Recent advances in understanding the biological underpinnings of PDAC have revealed potential vulnerabilities that can be targeted for treatment.

GENES & DEVELOPMENT (2021)

Article Biochemistry & Molecular Biology

A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo

Ana Maria Zarate et al.

Summary: A study designed and synthesized new SMO antagonists with compound 4s showing the most active inhibition of cell growth, selective cytotoxicity to cancer cells, and the ability to induce cell cycle arrest and apoptosis. In vivo, 4s strongly inhibited tumor relapse and metastasis of melanoma cells in mice, and in vitro, it was more effective than vismodegib in inducing apoptosis in human cancer cells as a SMO antagonist and apoptosis inducer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

New aryloxy-quinone derivatives with promising activity on Trypanosoma cruzi

Christian Espinosa-Bustos et al.

ARCHIV DER PHARMAZIE (2020)

Review Pharmacology & Pharmacy

Developing effective combination therapy for pancreatic cancer: An overview

Aubrey L. Miller et al.

PHARMACOLOGICAL RESEARCH (2020)

Review Oncology

Systemic treatment of pancreatic cancer revisited

Michel Ducreux et al.

SEMINARS IN ONCOLOGY (2019)

Article Chemistry, Organic

Rapid Access to Benzofuran-Based Natural Products through a Concise Synthetic Strategy

Maddali L. N. Rao et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2016)

Review Biotechnology & Applied Microbiology

Twenty years on: the impact of fragments on drug discovery

Daniel A. Erlanson et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Article Chemistry, Medicinal

2-Phenoxy-1,4-naphthoquinones: From a Multitarget Antitrypanosomal to a Potential Antitumor Profile

Federica Prati et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

Article Chemistry, Organic

Total synthesis of the 2-arylbenzo[b]furan-containing natural products from Artocarpus

Deyan Wu et al.

TETRAHEDRON LETTERS (2015)

Review Chemistry, Multidisciplinary

Understanding cancer and the anticancer activities of naphthoquinones - a review

Kevin W. Wellington

RSC ADVANCES (2015)

Article Biochemistry & Molecular Biology

2-Phenylaminonaphthoquinones and related compounds: Synthesis, trypanocidal and cytotoxic activities

Ivan Sieveking et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Synthesis and biological characterization of new aryloxyindole-4,9-diones as potent trypanosomicidal agents

Ricardo A. Tapia et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

Article Chemistry, Multidisciplinary

Quantification of the Ambident Electrophilicities of Halogen-Substituted Quinones

Xingwei Guo et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Article Chemistry, Organic

Antitumour indolequinones: synthesis and activity against human pancreatic cancer cells

Martyn Inman et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: Excellent substrates for NAD(P)H:quinone oxidoreductase 1

Jeffery J. Newsome et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2013)

Article Infectious Diseases

Naphthoquinone Derivatives Exert Their Antitrypanosomal Activity via a Multi-Target Mechanism

Simone Pieretti et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Article Chemistry, Multidisciplinary

A practicable environmentally benign one-pot synthesis of 2-arylbenzofurans at room temperature

Lian-Yan Liao et al.

GREEN CHEMISTRY (2012)

Review Biotechnology & Applied Microbiology

Vemurafenib: the first drug approved for BRAF-mutant cancer

Gideon Bollag et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Chemistry, Medicinal

Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design

Nicholas A. Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2011)

Review Gastroenterology & Hepatology

Phenotype and Genotype of Pancreatic Cancer Cell Lines

Emily L. Deer et al.

PANCREAS (2010)

Article Biochemistry & Molecular Biology

Studies on quinones. Part 45: Novel 7-aminoisoquinoline-5,8-quinone derivatives with antitumor properties on cancer cell lines

Jaime A. Valderrama et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)

Article Chemistry, Medicinal

Synthesis and antifungal activity of benzo[d]oxazole-4,7-diones

Chung-Kyu Ryu et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Article Chemistry, Multidisciplinary

Intramolecular cross-coupling of gem-dibromoolefins: a mild approach to 2-bromo benzofused heterocycles

Stephen G. Newman et al.

CHEMICAL COMMUNICATIONS (2009)

Article Chemistry, Multidisciplinary

The rise of fragment-based drug discovery

Christopher W. Murray et al.

NATURE CHEMISTRY (2009)

Article Biochemistry & Molecular Biology

Trypanosoma cruzi:: Activities of lapachol and α- and β-lapachone derivatives against epimastigote and trypomastigote forms

Cristian Salas et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2008)

Review Chemistry, Multidisciplinary

Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds

Elizabeth Anne Hillard et al.

CHEMICAL COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

Some benzoxazoles and benzimidazoles as DNA topoisomerase I and II inhibitors

Emine Oksuzoglu et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2008)

Article Chemistry, Multidisciplinary

A short history of SHELX

George M. Sheldrick

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)

Article Chemistry, Organic

Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H : quinone oxidoreductase 1

Jeffery J. Newsome et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2007)

Article Pharmacology & Pharmacy

An estrogen receptor-β agonist is active in models of inflammatory and chemical-induced pain

Liza Leventhal et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2006)

Review Chemistry, Multidisciplinary

Antitumor antibiotics: Bleomycin, endiynes, and mitomycin

U Galm et al.

CHEMICAL REVIEWS (2005)

Article Chemistry, Organic

Synthesis and studies of 1,4,5,8,9,12,13,16-octamethoxytetraphenylene

CW Lai et al.

ORGANIC LETTERS (2003)

Article Chemistry, Medicinal

Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase

C Flader et al.

JOURNAL OF MEDICINAL CHEMISTRY (2000)